Dutrebis

Active Ingredient(s): Lamivudine + Raltegravir
FDA Approved: * February 6, 2015
Pharm Company: * MERCK SHARP DOHME
Category: HIV / AIDS

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Dutrebis Overview

Raltegravir, sold under the brand name Isentress, is an antiretroviral medication used, together with other medication, to treat HIV/AIDS.[4] It may also be used, as part of post exposure prophylaxis, to prevent HIV infection following potential exposure.[5] It is taken by mouth.[4] Common side effects include trouble sleeping, feeling tired, nausea, high blood sugar, and headaches.[5] Severe side effects may include allergic rea...

Read more Dutrebis Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Raltegravir

Recent Dutrebis Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Lamivudine + Raltegravir
  • Tablet: 150mg + 300mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Drugs with one or more similar ingredients: (22 results)